124P Phase II study of neoadjuvant concurrent chemo-immuno-radiation therapy followed by surgery and adjuvant immunotherapy for resectable stage IIIA-B N2 non-small cell lung cancer: SQUAT trial (WJOG 12119L). (December 2022) - Miyoshi, T.; Hamada, A.; Soh, J.; Hata, A.; Nakamatsu, K.; Shimokawa, M.; Yatabe, Y.; Suzuki, J.; Tsuboi, M.; Horinouchi, H.; Yoshino, I.; Masayuki, T.; et al.